Redwood City, California, United States · Hybrid
$186k–$233k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Companion Diagnostics Development, Oncology Biomarkers, IVD Development, Regulatory Submissions, NGS
Redwood City, California, United States · Hybrid
$186k–$233k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Biostatistics, Clinical Trial Design, Oncology Trials, Statistical Analysis Plans, SAS
Redwood City, California, United States · Hybrid
$164k–$205k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Statistical Programming, Oncology Clinical Trials, CDISC Standards, SDTM, ADaM
Redwood City, California, United States · Hybrid
$211k–$264k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Pipeline Communications, Product Communications, Precision Oncology, Clinical Development, Regulatory Milestones
Redwood City, California, United States · Hybrid
$244k–$305k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Pharmacovigilance, Safety Surveillance, Signal Detection, Risk Management, Aggregate Reporting
Redwood City, California, United States · Hybrid
$261k–$300k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Pharmacovigilance, Medical Review, Case Assessment, Causality Assessment, MedDRA
Redwood City, California, United States · Hybrid
$211k–$264k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Pharmacovigilance, Signal Detection, Risk Management, Aggregate Reporting, Benefit-Risk Assessment
Redwood City, California, United States · Hybrid
$294k–$367k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Cancer Pharmacology, Translational Research, PK/PD, In Vivo Pharmacology, AI/ML Integration
Redwood City, California, United States · Hybrid
$186k–$233k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Quality Validation, cGMP Compliance, Process Performance Qualification, Continued Process Verification, Cleaning Validation
Redwood City, California, United States · Hybrid
$164k–$205k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Clinical Operations, Study Management, GCP, ICH Guidelines, FDA Regulations
Redwood City, California, United States · Hybrid
$244k–$305k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Commercial Drug Product Manufacturing, CMO Management, Process Validation, PPQ Execution, Continued Process Verification
Redwood City, California, United States · On-site
$132k–$166k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Drug Product Development, Solid Oral Dosage Forms, Preformulation, Process Scale-up, Technology Transfer
Redwood City, California, United States · Hybrid
$120k–$150k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Clinical Trial Accruals, Financial Reporting, SOX Compliance, Variance Analysis, Contract Analysis
Redwood City, California, United States · Hybrid
$346k–$397k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Clinical Development, Oncology, Regulatory Submissions, Data Integrity, Clinical Trial Design
Redwood City, California, United States · Hybrid
$244k–$305k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Global Regulatory Strategy, Health Authority Leadership, Regulatory Submission Leadership, Oncology Development, Cross-Functional Leadership
Redwood City, California, United States · Hybrid
$186k–$233k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Clinical Biomarker Strategy, Assay Development, Patient Sample Acquisition, CRO Management, Cancer Biology
Redwood City, California, United States · Hybrid
$211k–$264k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Clinical Data Management, Vendor Management, EDC Database Development, Case Report Forms, Medical Coding
Redwood City, California, United States · On-site
$251k–$295k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Machine Learning, Python, PyTorch, TensorFlow, Scikit-learn
Redwood City, California, United States · Hybrid
$267k–$306k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Healthcare Compliance, Risk Assessment, Pharmaceutical Regulations, Internal Investigations, Strategic Leadership
Redwood City, California, United States · Hybrid
$170k–$212k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Metabolite Identification, Structural Elucidation, High-Resolution Mass Spectrometry, Pharmacokinetic Data Analysis, WinNonlin
Redwood City, California, United States • Hybrid
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
Lead the development and implementation of global diagnostic strategies and companion diagnostics (CDx) to support the commercialization of oncology therapies. Oversee the validation of in vitro diagnostic assays and manage relationships with external Dx partners and health authorities.
Requires a postgraduate degree (MS/PhD) with 7-10+ years of industry experience in oncology biomarker or companion diagnostic development. Must have expertise in IVD regulatory processes and experience managing clinical trial assays.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
Revolution Medicines is offering a highly visible opportunity for talented and motivated individual to join our Precision Medicine Companion Diagnostics team as an Associate Director, Companion Diagnostics within the Translational Medicine function, which supports CDx development across RevMed portfolio. Through both scientific and cross-functional leadership, individual is to implement global diagnostic strategies to enable and support the global development and commercialization of medically differentiated therapies. The successful candidate will have the opportunity to work in a fast-paced, highly collaborative environment and will be a key member of multidisciplinary development project teams.
Lead the development and implementation of diagnostic strategies through registration and launch for individual clinical studies and/or molecule program.
Direct the development, outsourcing and validation of clinically applicable in vitro diagnostic assays through the development lifecycle of molecules, including design, implement and oversee diagnostic testing and registration strategy and timely communication with key internal and external stakeholders.
Provide expertise to development project teams to ensure access to state-of-the-art approaches on appropriate diagnostic technologies (e.g. NGS-based tissue and ctDNA assays, PCR, immunohistochemistry), evaluating their scientific basis and clinical applicability, the validation status and any technical or statistical issues related to the proposed companion diagnostic assay.
Oversee implementation of clinical trial assays at CRO laboratories for centralized testing supporting clinical trials. Monitors all scope or changes in study are timely implemented, including the development of the work order, costs and agreements.
Lead joint development teams between RevMed and Dx partners to ensure cross-functional alignment of overarching development, regulatory and commercialization strategy, successful fit for purpose CDx development and that co-development timelines are met.
Serve as subject matter expert in diagnostic regulation and support the interactions with global health authorities regarding companion diagnostics development and submissions.
Highly experienced biomarker or diagnostics professional (MS and/or PhD) with a minimum of 7-10 years of relevant industry experience with expertise in oncology biomarker and/or companion diagnostic development.
High level of initiative and ability to work independently with business awareness, hands on experience in IVD development processes and global in vitro diagnostic regulatory aspects related to companion diagnostic development.
Experience with biomarker application in clinical trials and awareness of the challenges of implementing diagnostic technologies in the clinical setting.
Experience with health authority interactions and regulatory submissions for pharmaceutical and/or in vitro diagnostics development globally.
Excellent leadership skills including motivation and influencing without authority.
Highly collaborative team player who fosters open communication and facilitates mutual understanding and cooperation between all stakeholders with excellent communication, analytical and organizational skills.
Cross-functional experience in commercial and or medical aspects of companion diagnostics is a plus.
#LI-Hybrid #LI-EM1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Revolution Medicine enables physicians to integrate personalized medicine into their practices in order to more effectively treat patients. Our genes play an important role in determining how we respond to about 75% of prescription drugs. Scientific research has demonstrated which genes predict these responses. According to the American Medical Association (AMA), 98% of physicians agree that knowing a patient’s genetic profile would help in prescribing medications. Yet, 90% of physicians do not feel they are adequately informed about how to apply genetic testing to treatment decisions. Our mission is to improve the quality of patient care by helping doctors determine optimal treatment strategies and more accurately predict treatment responses. Revolution Medicine has developed ScriptMatch, an analytical process that enables physicians to easily incorporate genetic testing into their practices. Our company solves a major issue in the clinical market and addresses an emerging trend in patient-driven healthcare: having clinical results that become part of the medical record and applicable to future treatments.
View all jobs at Revolution MedicineBased on 205 listings with disclosed salaries, most science & research jobs in Redwood City, CA pay between $109k–$265k per year. Individual offers vary with seniority, company size, and specialization.
There are currently 244 open science & research positions in Redwood City, CA listed on Clera. New openings are added daily as companies post roles.
Companies currently hiring include Revolution Medicine, Corcept Therapeutics, Luma, Abbott, Altos Labs, among others. Browse the listings above to see every active employer.
Yes — 148 of the 244 open science & research positions offer remote or hybrid work (15 remote, 133 hybrid).
Each listing links directly to the employer's application page. Apply early — fresh listings get the most recruiter attention in the first two weeks.
